Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors.
Anderson AE, Parashar K, Jin K, Clor J, Stagnaro CE, Vani U, Singh J, Chen A, Guan Y, Talukdar P, Sathishkumar P, Juat DJ, Singh H, Kushwaha R, Zhao X, Kaplan A, Seitz L, Walters MJ, Fernandez-Salas E, Walker NPC, Bowman CE.
Anderson AE, et al. Among authors: guan y.
Mol Cancer Ther. 2024 May 27. doi: 10.1158/1535-7163.MCT-23-0865. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 38797955